Lawrence F Eichenfield

33PUBLICATIONS
106CO-AUTHORS
Disease surveillanceInfant and child healthTraditional Chinese medicine and treatmentsAdolescent healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 11, 2026
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

|Mar 08, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).

Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz

|Feb 08, 2026
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States.

Jonathan I Silverberg, David Cohen, Emma Guttman-Yassky

|Apr 20, 2025
Patient-Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate-To-Severe Disease: Results of a Real-World, Cross-Sectional Survey.

Lawrence F Eichenfield, Vivian Y Shi, JiaDe Yu

|Feb 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.

Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette

|Feb 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.

Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati

Pageof 6

Frequent Collaborators

5 joint publications

Erin Almaraz

4 joint publications

Emma Guttman-Yassky

4 joint publications

Jonathan I Silverberg

3 joint publications

Daniel Sturm